These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 17143753)
1. Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer. Kalachandra S; Takamata T; Lin DM; Snyder EA; Webster-Cyriaque J J Mater Sci Mater Med; 2006 Dec; 17(12):1227-36. PubMed ID: 17143753 [TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate. Tallury P; Alimohammadi N; Kalachandra S Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460 [TBL] [Abstract][Full Text] [Related]
3. EVA copolymer matrix for intra-oral delivery of antimicrobial and antiviral agents. Ramadevi A; Padmavathy T; Stigall G; Paquette D; Kalachandra S J Mater Sci Mater Med; 2008 Feb; 19(2):721-7. PubMed ID: 17619973 [TBL] [Abstract][Full Text] [Related]
4. Drug release from cast films of ethylene vinyl acetate (EVA) copolymer: Stability of drugs by 1H NMR and solid state 13C CP/MAS NMR. Kalachandra S; Lin DM; Stejskal EO; Prakki A; Offenbacher S J Mater Sci Mater Med; 2005 Jul; 16(7):597-605. PubMed ID: 15965590 [TBL] [Abstract][Full Text] [Related]
5. Controlled drug release for oral condition by a novel device based on ethylene vinyl acetate (EVA) copolymer. Kalachandra S; Dongming L; Offenbacher S J Mater Sci Mater Med; 2002 Jan; 13(1):53-8. PubMed ID: 15348205 [TBL] [Abstract][Full Text] [Related]
6. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release. Lin DM; Kalachandra S; Valiyaparambil J; Offenbacher S Dent Mater; 2003 Nov; 19(7):589-96. PubMed ID: 12901982 [TBL] [Abstract][Full Text] [Related]
7. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. Tallury P; Randall MK; Thaw KL; Preisser JS; Kalachandra S Dent Mater; 2007 Aug; 23(8):977-82. PubMed ID: 17049593 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release. Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834 [TBL] [Abstract][Full Text] [Related]
9. Release of antimicrobial and antiviral drugs from methacrylate copolymer system: effect of copolymer molecular weight and drug loading on drug release. Tallury P; Airrabeelli R; Li J; Paquette D; Kalachandra S Dent Mater; 2008 Feb; 24(2):274-80. PubMed ID: 17628658 [TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Cho CW; Choi JS; Yang KH; Shin SC Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946 [TBL] [Abstract][Full Text] [Related]
11. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix. Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151 [TBL] [Abstract][Full Text] [Related]
12. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems. Shin SC; Lee HJ Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692 [TBL] [Abstract][Full Text] [Related]
13. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems. Schneider C; Langer R; Loveday D; Hair D J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964 [TBL] [Abstract][Full Text] [Related]
14. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide. Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Lesser GJ; Grossman SA; Leong KW; Lo H; Eller S Pain; 1996; 65(2-3):265-72. PubMed ID: 8826516 [TBL] [Abstract][Full Text] [Related]
16. Effect of ethylene-vinyl acetate concentration on ethylcellulose-walled microcapsules: preparation and release kinetics of theophylline microcapsules. Lin SY; Yang JC J Microencapsul; 1985; 2(4):315-25. PubMed ID: 3880491 [TBL] [Abstract][Full Text] [Related]
17. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties. Guo Q; Guo S; Wang Z J Control Release; 2007 Apr; 118(3):318-24. PubMed ID: 17289208 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of atenolol from the ethylene-vinyl acetate matrix. Kim J; Shin SC Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126 [TBL] [Abstract][Full Text] [Related]
19. The effect of the Nb2O5 dispersion on ethylene vinyl acetate to obtain ethylene vinyl acetate/Nb2O5 nanostructured materials. Valentim AC; Tavares MI; da Silva EO J Nanosci Nanotechnol; 2013 Jun; 13(6):4427-32. PubMed ID: 23862516 [TBL] [Abstract][Full Text] [Related]
20. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer. Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]